TESTING TESTING 123

TIC TOC AND AWAY WE GO!

JUST MOVE ALONG NOTHING TO SEE HERE.

ALL WE NEED NOW ARE SOME OF THOSE FLUFFY SHARES TO GO ALONG WITH ALL THESE FLUFFY PRESS RELEASES

TESTING TESTING 123

What year was this? Anything current you might like to add maybe about ongoing trails at the present time.

Sure is a lot of buying today! What a deal if you have the time to wait for the buyout! I guess if I were millions of shares short I also would be trying to drive the price down!

There is more than a trail of bread crumbs being left behind. A serious investigation would be interesting to see at some point in the future.

You would of thought by now everybody would have stopped covering the short interest. Looks like free money from here on out. Why don't you put the word out. Someone hasn't got the message yet!

There has never been a big sell off of ANY stock even with everything that has happened in the past. The short interest ticked up again last period. There must be a lot of unhappy shorts somewhere out there. Is it time for another artificial sell off? Have to say I am encouraged with ANY's progress of late. I wonder just how much the share price would rise if we had some real covering. I am looking forward to more of those short stories but lets have something new every now and then.

Still trying to spin the old reverse split. We can't believe the CEO but we're suppose to believe you. I can't wait to buy more at a lower price and I am losing 5000 for every penny it goes lower. This will be a very successful company at some point. I really have not lost anything because I have not sold anything. No worries here!

I am curious to see how this short escapade turns out. I guess I will find out the next time the short interest is posted. I will be expecting another large decline in the short interest. This would almost be believable if there were some real news behind it. Just another day in shortsville.

If Leo were to buy shares someone would spin it into something negative. It would probably hurt the share price. Leo is doing exactly what he is suppose to be doing. He will be rewarded just like all the other investors as the science moves forward.

Sad! No one will even respond to the negative posters any more not even the share price! Sounds like a lot of hooey to me.

You guys better get everybody in line. Someone jumped ship and covered about 70,000 shares of the legit short interest. Don't they know this is going to zero according to some here. You better enlighten them a little in the near future.

Like my first boss said if you can't dazzle them with brilliance baffle them with BS!

I guess it is just a coincidence that these same stocks you speak so highly of were heavily shorted.

Could be trouble for shorts. Only one reason for such nonsense. Breaking a dollar want help the shorts. There are not enough shares to cover easily. Many here are posting like there life depends on it.

To funny.

Have fun !!!

I've got it now. So the logical answer is not the logical answer. It is like all these negative posts do not mean there is a large undeclared short position. Nobody can even have a good viewpoint about the company without moe shooting it down before a like minded individual can even reply. I hope there is a better plan out there to cover that position. Although it is very irritable it want impact the share price much.

Why would any big player show there hand? To help spiffy! I don't think so. They would want it for as little as possible.

We need some clarity here. I would think the numbers are pretty good if it is 2:00pm instead of after hours.

Just went to web sight 2:00 pm

There have been amazing developments in the revenue channels these last few months that have not even had a chance to bear fruit! I for one am going to give ANY a little time here to see how this all pans out. I think there will be more good surprises coming our way. Keeping my fingers crossed though on last quarters results even though the future looks bright!

They sure have everyone fooled. I think getting Microsoft, VMware and Novarad to go along with the ploy sure did the trick. I guess $7500.00 will buy a lot these days.

Have a great day!

Sounds to me like a lot of idiots shorted any and are having a hard time covering. We will see before the year is out! I personally am not expecting any change in sentiment or revenues until present quarters results are out. There will probably be a lot of noise about results for last quarter coming soon but it will be short lived. It definitely want be enough for the short interest to be covered and probably last mediocre numbers from ANY. I think some folks should start worrying about there borrowing cost at this price level.

The tweet speaks for itself no need to even debate it. They are clearly acknowledging S3D's importance in the project. All you have to look at is the source of the tweet. Apparently they think it is important or they would not have said it.

The only thing that really matters about the shorts is the short interest which will be conveniently posted after the close today for all to see!

Q4 results are already baked into this share price. The original call has been retracted long ago. It looks like the only fuss being raised here is by the short cabal hoping to promote a last ditch massive dump on the results. I will be a buyer here if that happens again!
It is a funny thing here that there are no shares to borrow but the short interest is going back up. Still manipulation going on here. We will see on the 9th when the next short interest is posted if that is the case.

Most people I believe are looking at the present quarter for future guidance. This seems to be when things are happening.

The best public service announcements are on the ANY message board! Last year and all the others ones in the past are history! This is the one that is going to count going forward. Sphere3D is in the best position it has ever been in for creating revenue. I think we can all forget about last quarter. No more excuses from now on though.
I predict the short interest is heading for all time new highs in the near future. There have probably already been a couple hundred thousand shares shorted in the last few days to hold it back and knock it down .30 cent. LOL! Looks like a good trade off to me. A real good game of chicken here going forward until revenue starts to roll in along with more partners.

My bag will be getting bigger! Plan on buying more as soon as possible. I apparently have more time to wait for things to materialize than the shorts. No worries here.

Revenue is the most important part of Any's future. Unfortunately, we are only going to get snapshots of that quarterly. The big news is VMware and MSFT. It does not matter who is selling the product. What matters is the product will be selling. Once the word gets out the products will be selling itself. You need to look at the big picture not what employees have left the company. Look at one of there new hires SB. I think people joining not leaving the company tell the biggest story.

Sirinvestalot

Keep up the good work! What ever you are doing here seems to be helping the share price lately. I am sure the fire works are coming. Must be hard trying to cover with an ever increasing share price. Might just have to short some more to hold it back.

Will be adding to my pile of shares in the mean time. All is well with ANY!!!

It's amazing! Just a little bit of buying pressure these last two weeks and the short interest goes up a 100,000. I do not believe that was by choice considering it has been steadily declining for some time now. Does not look like the time to leave to me but we shall see shortly!

I just can't figure out why the short interest keeps going down with those prices right around the corner. Go figure

Yet the shorts keep covering! Does not make a whole lot of since. Why would a short cover when we are going bankrupt. I guess it is just the fear of the unknown. I thought the shorts were smarter than that but maybe they are and that is why they are covering now!

At this share price the company is only going to need modest sales increases quarter over quarter for big gains in sp. Current share price does not really say much about future potential. Just wait for that first big increase in revenue and it is off to the races.

Everything going to Windows 10/Azure will help our future growth.

Microsoft Corporation and Hewlett Packard Enterprise Co. Team Up in the Cloud
Microsoft and HPE just unveiled a new cloud and mobility platform for businesses.

Leo Sun (TMFSunLion) Nov 23, 2015 at 3:00PM
Microsoft (NASDAQ:MSFT) and Hewlett-Packard Enterprise (NYSE:HPE) recently unveiled Cloud Productivity and Mobility Solution Offerings (CPM), which will integrate HPE's consulting services with Microsoft services within Windows 10. HPE will integrate its consulting services into Microsoft's SaaS (software as a service) platforms, including Office 365, Skype for Business, Dynamics CRM, and Enterprise Mobility Suite. Microsoft believes these integrations will "help organizations share information faster, increase engagement and collaboration, and optimize work."

Image

SOURCE: PIXABAY.

Microsoft previously partnered with HPE across the healthcare, financial, and automotive industries. For example, HPE's Automotive Aftersales CX Management Solution, built on Dynamics CRM, extracts information from connected cars so automakers can deliver personalized offers (like infotainment, concierge services, app downloads, and fuel services) to customers. Microsoft plans to expand its partnership with HPE into the retail, energy, and transportation industries as well.

What this partnership means for Microsoft
Strengthening the bonds between Windows 10 and the cloud is the crux of Microsoft CEO Satya Nadella's "mobile first, cloud first" strategy. Instead of relying heavily on Windows license revenues, Nadella wants Microsoft to generate more sustainable revenues from services tethered to its Windows 10 ecosystem. Nadella believes this strategy will help Microsoft generate $20 billion in cloud revenues by fiscal 2018, more than double its annual run rate of $8.2 billion last quarter.

The majority of Microsoft's cloud revenues come from SaaS platforms like Office 365 and Dynamics CRM. Last quarter, Microsoft's Office 365 revenue rose 70% annually on a constant currency basis. 3 million new subscribers signed up for the productivity suite, boosting its total subscriber base to 18.2 million. Dynamics revenue rose 12%, and its online enterprise base more than tripled.

Deeper integration with HPE's consulting services will ensure that both companies stay on the same page as the Windows 10 enterprise ecosystem expands. The partnership can also help Microsoft's Enterprise Mobility Suite (EMS) fend off rivals like BlackBerry's (NASDAQ:BBRY) BlackBerry Enterprise Service (BES). Both services help businesses monitor employees' mobile devices, which is becoming increasingly important due to the relaxation of BYOD (bring your own device) restrictions.

What this partnership means for HPE
After splitting with HP Inc., HPE mainly sells enterprise computer systems, software, and business support services. Prior to the split, HP shuttered its public cloud platform, Helion, which competes against Microsoft's Azure, to focus HPE's future on "hybrid cloud" installations instead.

Hybrid cloud installations merge private and public clouds for large companies that aren't ready to move all their data to the public cloud. Gartner estimates that about half of all large enterprises will use hybrid cloud installations by 2017. HPE is also dramatically reducing the size of its ES (Enterprise Services) division to cut costs. The company plans to lay off 25,000 to 30,000 employees to achieve $2 billion in gross annualized cost reductions and a sustainable operating margin between 7% to 9%.

Despite these strategic shifts, HPE estimates that its total cloud revenue (from its enterprise group, and software/enterprise service segments) will still rise 20% annually to $3 billion in fiscal 2015. Looking ahead, HPE's slimmed down ES division will benefit from partnering with Microsoft, since it can piggyback off Windows 10 Enterprise and Microsoft's other SaaS platforms. This means that it can spend less on marketing to achieve its cost reduction targets.

While deepening its partnership with Microsoft is a positive development, investors should note that HPE still faces plenty of headwinds. During its final quarter under HP, HP's enterprise services revenue fell 11% annually as demand for IT services, apps, and business services all fell.

A new growth market for mature tech giants
Microsoft, HPE, and many other "mature" tech giants are expanding their cloud and mobility offerings to diversify away from aging core businesses. For Microsoft, the cloud and mobility markets represent new ways to keep enterprise users locked into its ecosystem. For HPE, CPM represents a way to stay closely tied to Microsoft's dominance of the enterprise PC market.

It's going straight up! The short interest that is!!!

Price goes down. Short interest goes up! When will they learn?

On a happier note!

@OverlandStorage: @Sphere3D installed Glassware 2.0 at DLC Mortgage Village with zero disruption to business processes...in under 1hr! https://t.co/UZ8aAJnUPO

There product will be on the Azure platform probably with our help.

Did not intend to post entire link. I do believe that some parts relate to S3D/Azure collaboration.

Nvidia unveils hyperscale data center platform for deep learning - ZDNet
https://apple.news/AVhuBQsd5M2CYZTQCFBwADA

Short interest up 178,000!!!

Weeee !!

As some on this board would say!!!

$1.00 before $100.00 sounds better since neither one is based on fact.

Old update gives us a pretty good idea of their plans. They might have missed the mark a couple of times but there still on track to reach these goals.

Cellceutix Update 09/24/13

Beverly, MA -- 09/24/13 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering, developing and commercializing drugs to treat unmet medical conditions, is pleased to inform shareholders about progressions in the development of Brilacidin™, a novel small molecule antibiotic, and Kevetrin™, the Company’s anti-cancer drug being evaluated for the treatment of solid tumors at Harvard University’s Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center.

Cellceutix has met with the Contract Research Organization (CRO) that was responsible for the successful completion of the Phase 2a clinical trial of Brilacidin for acute bacterial skin and skin structure infections, or ABSSSI. With the newest information, Cellceutix will now request a meeting with the U.S. Food and Drug Administration to discuss protocol for a Phase 2b trial that is planned to be held at multiple centers worldwide.

“Just like everyone else that we’ve met with to discuss Brilacidin, the CRO was extremely impressed with the results from the clinical trial, as the drug was efficacious at a variety of dosing levels,” said Leo Ehrlich, Chief Executive Officer of Cellceutix. “They provided us valuable insight in outlining the structure of a Phase 2b trial, which we are confident will be short in duration with the primary goal of defining optimum dosing levels for the Phase 3 trial. We will discuss with the FDA the clinical protocol and our intentions to file for a Fast Track designation. Further, we are investigating commercialization potential of Brilacidin internationally that we believe may be a possibility before even a Phase 3 trial is complete. Brilacidin was very effective and impressive to the clinicians in the completed Phase 2a trial.”

Regarding Kevetrin, Cellceutix would like to inform shareholders that the fifth cohort has been completed and we anticipate the dosing will be increased for the next cohort.

“We have excellent researchers within our company. As we transition to multiple clinical trials we will be shifting resources to support our focus on clinical programs for Kevetrin, Brilacidin and Prurisol,” added Mr. Ehrlich. “We believe that conducting a significant number of clinical trials with our very strong pipeline is the key to fast significant growth at Cellceutix.”

About Cellceutix

Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol "CTIX". Cellceutix is a clinical stage biopharmaceutical company focused on developing and commercializing its pipeline of compounds for novel therapies in areas of serious unmet medical need, including cancer, psoriasis and antibiotic applications. More information is available on the Cellceutix web site at www.cellceutix.com.

Safe Harbor Forward-Looking Statements

To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Factors that may impact Cellceutix's success are more fully disclosed in Cellceutix's most recent public filings with the U.S. Securities and Exchange Commission.

There will be a lot of takers at that price! Count me in on that deal.